| abstract |
Pharmacological combinations which, together with a compound 1 (6-hydroxy-8- {1-hydroxy-2- [2- (4-methoxy-phenyl) -1,1-dimethyl-ethylamino] -ethyl} -4H-benzo [ 1,4] oxazin-3-one), in the form of the different optical isomers, mixtures of the different enantiomers or racemates, of the salts by the addition of acids with pharmacologically safe acids, as well as, in the form of solvates and / or hydrates; as another active ingredient 2 contain a tiotropium salt 2a and ciclesonide 2b. |